Immunization Safety Review Committee
Meeting 9: Vaccines and Autism

The National Academy of Sciences, Auditorium
2100 C Street NW,
Washington, DC 20418
February 9, 2004

Agenda

8:00 - 8:15 am Welcome and Opening Remarks
Marie McCormick, M.D., ScD, Committee Chair

8:15 - 8:30 Congressional Speakers
Congressman Dave Weldon, U.S. House of Representatives

 8:30-9:30 Etiologic factors and pathogenesis of autism: evidence from
 clinical studies and animal models 
Mady Hornig, M.D., Associate Professor, Columbia University
 Mailman School of Public Health 

9:30-10:00 Association of Autistic Spectrum Disorder and MMR Vaccine: A Systematic Review of Current Epidemiological Evidence
Kumanan Wilson, M.D., MSc, Division of Clinical Decision Making
 and Health Care, Toronto General Research Institute, Canada

10:00 - 10:30 Age at First Measles-Mumps-Rubella Vaccination in Children with Autism and School-Matched Control Subjects
Frank DeStefano, MD, Centers for Disease Control and Prevention

10:30 -10:45 Break

10:45-11:15 Exposure to Thimerosal-Containing Vaccines in UK Children and Autism
Dr. Elizabeth Miller, Head, Immunisation Division, Public Health 
Laboratory Service, Communicable Disease Surveillance Centre, 
London, UK

11:15-11:45 Vaccine Safety Datalink Study: Autism Outcome
 Robert L. Davis, M.D., M.P.H., University of Washington Group 
 Health, Cooperative Depts. of Pediatrics Center for Health Studies
 and Epidemiology

11:45-12:15 Study of the Association Between Thimerosal-Containing Vaccine and Autism in Denmark
Anders Peter Hviid, MSc, Department of Epidemiology Research
State Serum Institute, Copenhagen, Denmark

12:15-12:45 Autism and thimerosal-containing vaccines: analysis of the Vaccine Adverse Events Reporting System (VAERS)
Mark R. Geier, M.D., Ph.D., President, The Genetic Centers of America
David Geier, President of MedCon
 
12:45-1:45 Lunch

1:45 - 2:15 A Toxicologist's View of Thimerosal and Autism
H. Vasken Aposhian, Ph.D., Professor, Molecular and Cellular Biology
University of Arizona

2:15-2:45 Relation of Neurotoxic Effects of Thimerosal to Autism
David Baskin, M.D., Professor of Neurosurgery and Anesthesiology, 
Baylor College of Medicine

2:45-3:15 Thimerosal Exposure From Vaccines and Ethylmercury Accumulation in Non-human Primates
Dr. Polly Sager, Assistant Director for International Research, National 
Institute of Allergy and Infectious Diseases

3:15-3:30 Break

3:30-4:00 Reduced Levels of Mercury in First Baby Haircuts of Autistic Children
Boyd Haley, Ph.D., Chairman and Professor, Department of Chemistry, 
University of Kentucky

4:00-4:30 A Case-control Study of Mercury Burden in Children with Autistic Disorders and Measles Virus Genomic RNA in Cerebrospinal Fluid in Children with Regressive Autism
Jeff Bradstreet, M.D., FAAFP, Adjunct Professor, Neurosciences,
 Stetson University, Director of Clinical Programs, International Child
 Development Resource Center, Florida

4:30-5:00 Autism, Vaccines, and Immune Reactions
Vijendra K. Singh, Ph.D., Research Associate Professor
Utah State University

5:00-5:30 Public Comment Period

5:30 pm Adjourn